Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report for Connecticut by County

Non-Hodgkin Lymphoma (All Stages^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
County
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
Connecticut 7 21.3 (20.7, 21.9) N/A 968 stable stable trend 0.1 (-0.1, 0.3)
US (SEER+NPCR) 1 19.0 (18.9, 19.0) N/A 71,841 falling falling trend -1.8 (-2.4, -1.3)
Middlesex County 7 24.2 (21.4, 27.3) 1 (1, 4) 58 stable stable trend 0.9 (0.0, 1.7)
New Haven County 7 23.1 (21.8, 24.4) 2 (1, 4) 252 stable stable trend 0.0 (-0.3, 0.4)
Windham County 7 22.8 (19.4, 26.7) 3 (1, 8) 33 stable stable trend 0.7 (-0.3, 1.8)
Fairfield County 7 21.1 (19.9, 22.4) 4 (2, 7) 243 stable stable trend 0.1 (-0.3, 0.4)
New London County 7 20.0 (17.9, 22.4) 5 (3, 8) 70 stable stable trend 5.1 (-0.3, 10.7)
Hartford County 7 19.9 (18.7, 21.1) 6 (4, 8) 224 stable stable trend 0.0 (-0.3, 0.4)
Litchfield County 7 19.5 (17.2, 22.2) 7 (3, 8) 55 stable stable trend 0.1 (-1.1, 1.2)
Tolland County 7 19.2 (16.3, 22.5) 8 (3, 8) 32 stable stable trend -0.1 (-1.0, 0.9)
Notes:
Created by statecancerprofiles.cancer.gov on 12/08/2022 5:43 am.

State Cancer Registries may provide more current or more local data.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.

Return to Top